Please assess the completion status of the following clinical trial:

Trial Title: Pilot RCT Feasibility Study: Cancer and T2D

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* a) 18 years and older~* b) Using pathology reports, a new diagnosis of a solid tumor cancer or lymphoma within the past 3 months~* c) Patients being treated with curative intent or those with a prognosis estimated to be \>2 years, as best assessed by the oncologist.~* d) First medical oncology outpatient visit at UF within the past 3 months~* e) Plans to continue cancer care at UF~* f) Speaks and reads English~* g) Can comply with study related procedures, per the treating oncologist or advanced practice provider~Exclusion Criteria:~* a) Diagnosis of leukemia or pancreatic cancer as the new cancer diagnosis~* b) Being treated for T2D for \> than 3 months~* c) eGFR \<45mL/minute/1.73m2~* d) Liver insufficiency (defined as liver enzymes over 5 times the upper limit of normal or clinical sequelae of advanced cirrhosis as documented by the treating oncologist or Advanced Practice Providers.~* e) Active infection requiring systemic antibiotics~* f) Taking systemic steroids of more than 1-week duration. Must have stopped \>3 days prior to study enrollment. Note, inhaled or topical steroids are not exclusion criteria.~* g) Planning to receive cancer care at a location outside of UF~* h) Enrolled in another study with similar outcomes.~* i) Currently taking metformin or known inability to tolerate it

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Nurse-led (Type: EXPERIMENTAL): Nurse-led (group A). Patients randomized to group A will be taken to an available consultation room within the clinic and provided brief diabetes education which includes understanding what it means to have diabetes, healthy eating, and physical activity. Patients will also receive instructions on how to use a glucometer and how to take Metformin.
- Usual Care (Type: NO_INTERVENTION): Usual Care (Control; group B). Patients randomized to usual care will be informed of their HbA1c value, will continue to receive usual cancer care, and will be encouraged to follow-up with their PCP for T2D management. The RA will ensure that oncology visit clinic notes and the results of the HbA1c testing are relayed to the patient's PCP office. Patients who do not have a PCP identified will be referred to an appropriate provider.

Based on this trial design, predict the completion outcome and termination type (if applicable).